Top Five Global Medical Equipment Companies: Performance, Strategies, and Competitive Analysis, December 2012
Technology advancements, portability, and fusion technology applications are expected to drive the global medical equipment industry. The industry experienced average growth over the last five years and is expected to reach approximately US $93.6 billion in 2017 with a CAGR of 4.1% over the next five years.
Lucintel, a leading global management consulting and market research firm, has conducted a competitive analysis of the global medical equipment companies and presents its findings in “Top Five Global Medical Equipment Companies: Performance, Strategies, and Competitive Analysis.” The report provides detailed insight into the performance of the top five companies across the world. The analysis highlights the companies that are performing the best among the peer group, and in which areas, and therefore clarifies leading performance standards and the strengths and weaknesses of companies covered.
The global medical equipment market consists of the total revenues generated through ophthalmic equipment such as retinal cameras and ophthalmoscopes; in vitro diagnostic such as clinical diagnostic and immunoassay; diagnostic imaging equipment including X-ray, MRI, CT scan, and ultrasound; and dental equipment. In this study, Lucintel profiles the following five companies with detailed competitive assessments:
This report will save hundreds of hours of your own personal research time and will significantly benefit you in expanding your business opportunities in global medical equipment companies industry. In today’s chaotic economy, you need every advantage that you can find to keep ahead in your business
Lucintel, a leading global management consulting and market research firm, has conducted a competitive analysis of the global medical equipment companies and presents its findings in “Top Five Global Medical Equipment Companies: Performance, Strategies, and Competitive Analysis.” The report provides detailed insight into the performance of the top five companies across the world. The analysis highlights the companies that are performing the best among the peer group, and in which areas, and therefore clarifies leading performance standards and the strengths and weaknesses of companies covered.
The global medical equipment market consists of the total revenues generated through ophthalmic equipment such as retinal cameras and ophthalmoscopes; in vitro diagnostic such as clinical diagnostic and immunoassay; diagnostic imaging equipment including X-ray, MRI, CT scan, and ultrasound; and dental equipment. In this study, Lucintel profiles the following five companies with detailed competitive assessments:
- Abbott
- General Electric
- Philips
- Roche
- Siemens
This report will save hundreds of hours of your own personal research time and will significantly benefit you in expanding your business opportunities in global medical equipment companies industry. In today’s chaotic economy, you need every advantage that you can find to keep ahead in your business
1. EXECUTIVE SUMMARY
2. MARKET DEFINITION AND SCOPE
3. MARKET OPPORTUNITY
4. COMPETITIVE BENCHMARKING (FINANCIAL AND MARKET)
Company Profile on Following Parameters
Company Overview
Benchmarking (Financial & Market)
SWOT Analysis
Product Positioning
Marketing Strategy and Tactics
Corporate Strategy
5. COMPANY PROFILE ON ABBOTT
6. COMPANY PROFILE ON GENERAL ELECTRIC
7. COMPANY PROFILE ON PHILIPS
8. COMPANY PROFILE ON ROCHE
9. COMPANY PROFILE ON SIEMENS
2. MARKET DEFINITION AND SCOPE
3. MARKET OPPORTUNITY
4. COMPETITIVE BENCHMARKING (FINANCIAL AND MARKET)
Company Profile on Following Parameters
Company Overview
Benchmarking (Financial & Market)
SWOT Analysis
Product Positioning
Marketing Strategy and Tactics
Corporate Strategy
5. COMPANY PROFILE ON ABBOTT
6. COMPANY PROFILE ON GENERAL ELECTRIC
7. COMPANY PROFILE ON PHILIPS
8. COMPANY PROFILE ON ROCHE
9. COMPANY PROFILE ON SIEMENS
LIST OF FIGURES AND CHARTS
CHAPTER 3. Market Opportunity
Figure 3.1: Supply chain for medical equipment market
Figure 3.2: Global medical equipment industry annual trend 2006-2011 (US $B)
Figure 3.3: Global medical equipment industry regional trend 2006-2011 (US $B)
Figure 3.4: Global medical equipment industry regional trend 2006-2011 (%)
Figure 3.5: Global medical equipment industry segment trend 2006-2011 (US $B)
Figure 3.6: Global medical equipment industry segment trend 2006-2011 (%)
Figure 3.7: Global medical equipment industry opportunity by region
Figure 3.8: Global medical equipment industry opportunity by segment
CHAPTER 4.Competitive Benchmarking (Financial and Market)
Figure 4.1: Top five medical equipment companies – financial benchmarking
Figure 4.2: Global top five medical equipment companies gross profit and net profit analysis – 2011
Figure 4.3: Financial analysis – growth leadership quadrant (2011)
Figure 4.4: Market share of top players 2006
Figure 4.5: Market share of top players 2011
Figure 4.6: 2006 Market share analysis
Figure 4.7: 2011 Market share analysis
Figure 4.8: Global market share analysis 2011
Figure 4.9: Global market fragmentation 2011
Figure 4.10: Market value North America: (US $B)
Figure 4.11: Market value Europe (US $B)
Figure 4.12: Market value Asia Pacific (US $B)
Figure 4.13: Market value Row (US $B)
Figure 4.14: Regional revenue evaluation 2011(US $M)
Figure 4.15: Regional revenue evaluation 2011(%)
Figure 4.16: North American revenue trend for top players 2007-2011 (US $B)
Figure 4.17: Europe revenue trend for top players 2007-2011 (US $B)
Figure 4.18: Asia Pacific revenue trend for top players 2007-2011 (US $B)
Figure 4.19: Row revenue trend for top players 2007-2011 (US $B)
Figure 4.20: Lucintel triad - top five major players
CHAPTER 5. Company Profile of Abbott
Figure 5.1: Abbott’s revenue by business structure 2011
Figure 5.2: Lucintel Triad – Abbott
Figure 5.3: Financial benchmarking Abbott against top three and top five industry players’ average
Figure 5.4: Financial benchmarking of Abbott against Top Five best
Figure 5.5: Global industry revenue trend Vs Abbott (2007-2011) in US $B
Figure 5.6: Global market share trend for Abbott (2007-2011) in (%)
Figure 5.7: North American industry revenue trend Vs. Abbott 2007-2011 in (US $B)
Figure 5.8: European industry revenue trend Vs. Abbott 2007-2011 in (US $B)
Figure 5.9: APAC industry revenue trend Vs. Abbott 2007-2011 in (US $B)
Figure 5.10: ROW industry revenue trend Vs. Abbott 2007-2011 in (US $B)
Figure 5.11: North American market share trend Vs. Abbott 2007-2011 in (%)
Figure 5.12: European market share trend Vs. Abbott 2007-2011 in (%)
Figure 5.13: APAC market share trend Vs. Abbott 2007-2011 in (%)
Figure 5.14: ROW market share trend Vs. Abbott 2007-2011 in (%)
Figure 5.15: Abbott trend in R&D expenses 2007-2011 in US $M
Figure 5.16: Abbott trend in R&D expenses Percentage of total revenue
Figure 5.17: Comparison of Abbott SE R&D expenditure vs. top three & top five players average 2011
Figure 5.18: Abbott productivity 2007-2011 (US $M)
Figure 5.19: Abbott capital investment value 2007-2011 (US $M)
Figure 5.20: Strategic execution
CHAPTER 6. Company Profile of General Electric
Figure 6.1: General Electric revenue by business structure 2011
Figure 6.2: Lucintel triad - General Electric
Figure 6.3: Financial benchmarking of General Electric against top three and top five industry players’ average
Figure 6.4: Financial benchmarking of General Electric against Top five best
Figure 6.5: Global industry revenue trend Vs. General Electric (2007-2011) in (US $B)
Figure 6.6: Global market share trend for General Electric (2007-2011) in (%)
Figure 6.7: North American industry revenue trend Vs. General Electric 2007-2011 in (US $B)
Figure 6.8: European industry revenue trend Vs. General Electric 2007-2011 in (US $B)
Figure 6.9: APAC industry revenue trend Vs. General Electric 2007-2011 in (US $B)
Figure 6.10: ROW industry revenue trend Vs. General Electric 2007-2011 in (US $B)
Figure 6.11: North American market share trend Vs. General Electric 2007-2011 in (%)
Figure 6.12: European market share trend Vs. General Electric 2007-2011 in (%)
Figure 6.13: APAC market share trend Vs. DuPont 2007-2011 in (%)
Figure 6.14: ROW market share trend Vs. DuPont 2007-2011 in (%)
Figure 6.15: General Electric trend in R&D expenses 2007-2011 in US $M
Figure 6.16: General Electric trend in R&D expenses Percentage of total revenue
Figure 6.17: Comparison of General Electric SE R&D expenditure vs. top three & top five players average 2011
Figure 6.18: General Electric productivity: 2007-2011 in (US $M)
Figure 6.19: General Electric capital investment value: 2007-2011 in (US $M)
Figure 6.20: Strategic execution
CHAPTER 7. Company Profile of Philips
Figure 7.1: Philips revenue by business structure 2011
Figure 7.2: Lucintel triad – Philips
Figure 7.3: Financial benchmarking of Philips against top three and top five industry players’ average
Figure 7.4: Financial benchmarking of Philips against Top five best
Figure 7.5: Global industry revenue trend Vs. Philips (2007-2011) in (US $B)
Figure 7.6: Global market share trend for Philips (2007-2011) in (%)
Figure 7.7: North American industry revenue trend Vs. Philips (2007-2011) in (US $B)
Figure 7.8: European industry revenue trend Vs. Philips l (2007-2011) in (US $B)
Figure 7.9: APAC industry revenue trend Vs. Philips (2007-2011) in (US $B)
Figure 7.10: ROW industry revenue trend Vs. Philips (2007-2011) in (US $B)
Figure 7.11: North American market share trend Vs. Philips (2007-2011) in (%)
Figure 7.12: European market share trend Vs. Philips l (2007-2011) in (%)
Figure 7.13: APAC market share trend Vs. Philips (2007-2011) in (%)
Figure 7.14: ROW market share trend Vs. Philips (2007-2011) in (%)
Figure 7.15: Philips trend in R&D expenses 2007-2011 in US $M
Figure 7.16: Philips trend in R&D expenses Percentage of total revenue
Figure 7.17: Comparison of Philips R&D expenditure vs. top three & top five players average 2011
Figure 7.18: Philips productivity 2007-2011 in (US $M)
Figure 7.19: Philips capital investment value 2007-2011 in (US $M)
Figure 7.20: Strategic execution
CHAPTER 8. Company Profile of Roche
Figure 8.1: Roche revenue by business structure 2011
Figure 8.2: Lucintel triad – Roche
Figure 8.3: Financial benchmarking of Roche against top three and top five industry players’ average
Figure 8.4: Financial benchmarking of Roche against Top five best
Figure 8.5: Global industry revenue trend Vs. Roche (2007-2011) in (US $B)
Figure 8.6: Global market share trend for Roche (2007-2011) in (%)
Figure 8.7: North American industry revenue trend Vs. Roche (2007-2011) in (US $B)
Figure 8.8: European industry revenue trend Vs. Roche (2007-2011) in (US $B)
Figure 8.9: APAC industry revenue trend Vs. Roche (2007-2011) in (US $B)
Figure 8.10: ROW industry revenue trend Vs. Roche (2007-2011) in (US $B)
Figure 8.11: North American market share trend Vs. Roche (2007-2011) in (%)
Figure 8.12: European market share trend Vs. Roche (2007-2011) in (%)
Figure 8.13: APAC market share trend Vs. Roche (2007-2011) in (%)
Figure 8.14: ROW market share trend Vs. Roche (2007-2011) in (%)
Figure 8.15: Roche trend in R&D expenses 2007-2011 in US $M
Figure 8.16: Roche trend in R&D expenses Percentage of total revenue
Figure 8.17: Comparison of Roche R&D expenditure vs. top three & top five players average 2011
Figure 8.18: Roche productivity: 2007-2011 in (US $M)
Figure 8.19: Roche capital investment value: 2007-2011 in (US $M)
Figure 8.20: Strategic execution
CHAPTER 9. Company Profile of Siemens
Figure 9.1: Siemens revenue by business structure 2011
Figure 9.2: Lucintel triad – Siemens
Figure 9.3: Financial benchmarking of Siemens against top three and top five industry players’ average
Figure 9.4: Financial benchmarking of Siemens against Top five best
Figure 9.5: Global industry revenue trend Vs. Siemens (2007-2011) in (US $B)
Figure 9.6: Global market share trend for Siemens (2007-2011) in (%)
Figure 9.7: North American industry revenue trend Vs. Siemens (2007-2011) in (US $B)
Figure 9.8: European industry revenue trend Vs. Siemens (2007-2011) in (US $B)
Figure 9.9: APAC industry revenue trend Vs. Siemens (2007-2011) in (US $B)
Figure 9.10: ROW industry revenue trend Vs. Siemens (2007-2011) in (US $B)
Figure 9.11: North American market share trend Vs. Siemens (2007-2011) in (%)
Figure 9.12: European market share trend Vs. Siemens (2007-2011) in (%)
Figure 9.13: APAC market share trend Vs. Siemens (2007-2011) in (%)
Figure 9.14: ROW market share trend Vs. Siemens (2007-2011) in (%)
Figure 9.15: Siemens trend in R&D expenses 2007-2011 in US $M
Figure 9.16: Siemens trend in R&D expenses Percentage of total revenue
Figure 9.17: Comparison of IMERYS R&D expenditure Vs. top three & top five players average 2011
Figure 9.18: Siemens productivity 2007-2011 in (US $M)
Figure 9.19: Siemens capital investment value 2007-2011 in (US $M)
Figure 9.20: Strategic execution
CHAPTER 3. Market Opportunity
Figure 3.1: Supply chain for medical equipment market
Figure 3.2: Global medical equipment industry annual trend 2006-2011 (US $B)
Figure 3.3: Global medical equipment industry regional trend 2006-2011 (US $B)
Figure 3.4: Global medical equipment industry regional trend 2006-2011 (%)
Figure 3.5: Global medical equipment industry segment trend 2006-2011 (US $B)
Figure 3.6: Global medical equipment industry segment trend 2006-2011 (%)
Figure 3.7: Global medical equipment industry opportunity by region
Figure 3.8: Global medical equipment industry opportunity by segment
CHAPTER 4.Competitive Benchmarking (Financial and Market)
Figure 4.1: Top five medical equipment companies – financial benchmarking
Figure 4.2: Global top five medical equipment companies gross profit and net profit analysis – 2011
Figure 4.3: Financial analysis – growth leadership quadrant (2011)
Figure 4.4: Market share of top players 2006
Figure 4.5: Market share of top players 2011
Figure 4.6: 2006 Market share analysis
Figure 4.7: 2011 Market share analysis
Figure 4.8: Global market share analysis 2011
Figure 4.9: Global market fragmentation 2011
Figure 4.10: Market value North America: (US $B)
Figure 4.11: Market value Europe (US $B)
Figure 4.12: Market value Asia Pacific (US $B)
Figure 4.13: Market value Row (US $B)
Figure 4.14: Regional revenue evaluation 2011(US $M)
Figure 4.15: Regional revenue evaluation 2011(%)
Figure 4.16: North American revenue trend for top players 2007-2011 (US $B)
Figure 4.17: Europe revenue trend for top players 2007-2011 (US $B)
Figure 4.18: Asia Pacific revenue trend for top players 2007-2011 (US $B)
Figure 4.19: Row revenue trend for top players 2007-2011 (US $B)
Figure 4.20: Lucintel triad - top five major players
CHAPTER 5. Company Profile of Abbott
Figure 5.1: Abbott’s revenue by business structure 2011
Figure 5.2: Lucintel Triad – Abbott
Figure 5.3: Financial benchmarking Abbott against top three and top five industry players’ average
Figure 5.4: Financial benchmarking of Abbott against Top Five best
Figure 5.5: Global industry revenue trend Vs Abbott (2007-2011) in US $B
Figure 5.6: Global market share trend for Abbott (2007-2011) in (%)
Figure 5.7: North American industry revenue trend Vs. Abbott 2007-2011 in (US $B)
Figure 5.8: European industry revenue trend Vs. Abbott 2007-2011 in (US $B)
Figure 5.9: APAC industry revenue trend Vs. Abbott 2007-2011 in (US $B)
Figure 5.10: ROW industry revenue trend Vs. Abbott 2007-2011 in (US $B)
Figure 5.11: North American market share trend Vs. Abbott 2007-2011 in (%)
Figure 5.12: European market share trend Vs. Abbott 2007-2011 in (%)
Figure 5.13: APAC market share trend Vs. Abbott 2007-2011 in (%)
Figure 5.14: ROW market share trend Vs. Abbott 2007-2011 in (%)
Figure 5.15: Abbott trend in R&D expenses 2007-2011 in US $M
Figure 5.16: Abbott trend in R&D expenses Percentage of total revenue
Figure 5.17: Comparison of Abbott SE R&D expenditure vs. top three & top five players average 2011
Figure 5.18: Abbott productivity 2007-2011 (US $M)
Figure 5.19: Abbott capital investment value 2007-2011 (US $M)
Figure 5.20: Strategic execution
CHAPTER 6. Company Profile of General Electric
Figure 6.1: General Electric revenue by business structure 2011
Figure 6.2: Lucintel triad - General Electric
Figure 6.3: Financial benchmarking of General Electric against top three and top five industry players’ average
Figure 6.4: Financial benchmarking of General Electric against Top five best
Figure 6.5: Global industry revenue trend Vs. General Electric (2007-2011) in (US $B)
Figure 6.6: Global market share trend for General Electric (2007-2011) in (%)
Figure 6.7: North American industry revenue trend Vs. General Electric 2007-2011 in (US $B)
Figure 6.8: European industry revenue trend Vs. General Electric 2007-2011 in (US $B)
Figure 6.9: APAC industry revenue trend Vs. General Electric 2007-2011 in (US $B)
Figure 6.10: ROW industry revenue trend Vs. General Electric 2007-2011 in (US $B)
Figure 6.11: North American market share trend Vs. General Electric 2007-2011 in (%)
Figure 6.12: European market share trend Vs. General Electric 2007-2011 in (%)
Figure 6.13: APAC market share trend Vs. DuPont 2007-2011 in (%)
Figure 6.14: ROW market share trend Vs. DuPont 2007-2011 in (%)
Figure 6.15: General Electric trend in R&D expenses 2007-2011 in US $M
Figure 6.16: General Electric trend in R&D expenses Percentage of total revenue
Figure 6.17: Comparison of General Electric SE R&D expenditure vs. top three & top five players average 2011
Figure 6.18: General Electric productivity: 2007-2011 in (US $M)
Figure 6.19: General Electric capital investment value: 2007-2011 in (US $M)
Figure 6.20: Strategic execution
CHAPTER 7. Company Profile of Philips
Figure 7.1: Philips revenue by business structure 2011
Figure 7.2: Lucintel triad – Philips
Figure 7.3: Financial benchmarking of Philips against top three and top five industry players’ average
Figure 7.4: Financial benchmarking of Philips against Top five best
Figure 7.5: Global industry revenue trend Vs. Philips (2007-2011) in (US $B)
Figure 7.6: Global market share trend for Philips (2007-2011) in (%)
Figure 7.7: North American industry revenue trend Vs. Philips (2007-2011) in (US $B)
Figure 7.8: European industry revenue trend Vs. Philips l (2007-2011) in (US $B)
Figure 7.9: APAC industry revenue trend Vs. Philips (2007-2011) in (US $B)
Figure 7.10: ROW industry revenue trend Vs. Philips (2007-2011) in (US $B)
Figure 7.11: North American market share trend Vs. Philips (2007-2011) in (%)
Figure 7.12: European market share trend Vs. Philips l (2007-2011) in (%)
Figure 7.13: APAC market share trend Vs. Philips (2007-2011) in (%)
Figure 7.14: ROW market share trend Vs. Philips (2007-2011) in (%)
Figure 7.15: Philips trend in R&D expenses 2007-2011 in US $M
Figure 7.16: Philips trend in R&D expenses Percentage of total revenue
Figure 7.17: Comparison of Philips R&D expenditure vs. top three & top five players average 2011
Figure 7.18: Philips productivity 2007-2011 in (US $M)
Figure 7.19: Philips capital investment value 2007-2011 in (US $M)
Figure 7.20: Strategic execution
CHAPTER 8. Company Profile of Roche
Figure 8.1: Roche revenue by business structure 2011
Figure 8.2: Lucintel triad – Roche
Figure 8.3: Financial benchmarking of Roche against top three and top five industry players’ average
Figure 8.4: Financial benchmarking of Roche against Top five best
Figure 8.5: Global industry revenue trend Vs. Roche (2007-2011) in (US $B)
Figure 8.6: Global market share trend for Roche (2007-2011) in (%)
Figure 8.7: North American industry revenue trend Vs. Roche (2007-2011) in (US $B)
Figure 8.8: European industry revenue trend Vs. Roche (2007-2011) in (US $B)
Figure 8.9: APAC industry revenue trend Vs. Roche (2007-2011) in (US $B)
Figure 8.10: ROW industry revenue trend Vs. Roche (2007-2011) in (US $B)
Figure 8.11: North American market share trend Vs. Roche (2007-2011) in (%)
Figure 8.12: European market share trend Vs. Roche (2007-2011) in (%)
Figure 8.13: APAC market share trend Vs. Roche (2007-2011) in (%)
Figure 8.14: ROW market share trend Vs. Roche (2007-2011) in (%)
Figure 8.15: Roche trend in R&D expenses 2007-2011 in US $M
Figure 8.16: Roche trend in R&D expenses Percentage of total revenue
Figure 8.17: Comparison of Roche R&D expenditure vs. top three & top five players average 2011
Figure 8.18: Roche productivity: 2007-2011 in (US $M)
Figure 8.19: Roche capital investment value: 2007-2011 in (US $M)
Figure 8.20: Strategic execution
CHAPTER 9. Company Profile of Siemens
Figure 9.1: Siemens revenue by business structure 2011
Figure 9.2: Lucintel triad – Siemens
Figure 9.3: Financial benchmarking of Siemens against top three and top five industry players’ average
Figure 9.4: Financial benchmarking of Siemens against Top five best
Figure 9.5: Global industry revenue trend Vs. Siemens (2007-2011) in (US $B)
Figure 9.6: Global market share trend for Siemens (2007-2011) in (%)
Figure 9.7: North American industry revenue trend Vs. Siemens (2007-2011) in (US $B)
Figure 9.8: European industry revenue trend Vs. Siemens (2007-2011) in (US $B)
Figure 9.9: APAC industry revenue trend Vs. Siemens (2007-2011) in (US $B)
Figure 9.10: ROW industry revenue trend Vs. Siemens (2007-2011) in (US $B)
Figure 9.11: North American market share trend Vs. Siemens (2007-2011) in (%)
Figure 9.12: European market share trend Vs. Siemens (2007-2011) in (%)
Figure 9.13: APAC market share trend Vs. Siemens (2007-2011) in (%)
Figure 9.14: ROW market share trend Vs. Siemens (2007-2011) in (%)
Figure 9.15: Siemens trend in R&D expenses 2007-2011 in US $M
Figure 9.16: Siemens trend in R&D expenses Percentage of total revenue
Figure 9.17: Comparison of IMERYS R&D expenditure Vs. top three & top five players average 2011
Figure 9.18: Siemens productivity 2007-2011 in (US $M)
Figure 9.19: Siemens capital investment value 2007-2011 in (US $M)
Figure 9.20: Strategic execution
LIST OF TABLES
CHAPTER 3. Market Opportunity
Table 3.1: Industry parameters of global pulp and paper chemical industry
Table 3.2: Relative market attractiveness by region
Table 3.3: Regional revenue growth rate
Table 3.4: Segment revenue growth rate
CHAPTER 4. Competitive Benchmarking (Financial and Market)
Table 4.1: Financial benchmarking of top five global pulp and paper chemical companies
Table 4.2: Key financial parameters for top five pulp and paper chemical companies
Table 4.3: Regional revenue (US $B)
Table 4.4: Regional revenue (%)
Table 4.5: Competitors based on markets served
Table 4.6: Lucintel triad - Top five major players
CHAPTER 5. Company Profile of Abbott
Table 5.1: Market served: Abbott
Table 5.2: Lucintel triad – Abbott
Table 5.3: Financial Benchmarking of Abbott against best and against Top three and Top five industry players’ average
Table 5.4: Strategic execution – product positioning by segment
Table 5.5: Strategic execution – perceived customer value / quality
Table 5.6: Strategic execution – promotion / communications
Table 5.7: Strategic execution – product distribution by region
CHAPTER 6. Company Profile of General Electric
Table 6.1: Market served – General Electric
Table 6.2: Lucintel triad – General Electric
Table 6.3: Financial benchmarking of General Electric against best and against
Top three and Top five industry players’ average
Table 6.4: Strategic execution – product positioning by segment
Table 6.5: Strategic execution – perceived customer value / quality
Table 6.6: Strategic execution – promotion / communications
Table 6.7: Strategic execution – product distribution by region
CHAPTER 7. Company Profile of Philips
Table 7.1: Market served – Philips
Table 7.2: Lucintel triad – Philips
Table 7.3: Financial benchmarking of Philips against best and against Top three and Top five industry players’ average
Table 7.4: Strategic execution – product positioning by segment
Table 7.5: Strategic execution – perceived customer value / quality
Table 7.6: Strategic execution – promotion / communications
Table 7.7: Strategic execution – product distribution by region
CHAPTER 8. Company Profile of Roche
Table 8.1: Market served – Roche
Table 8.2: Lucintel triad – Roche
Table 8.3: Financial Benchmarking of Roche against best and against Top three and top five industry players’ average
Table 8.4: Strategic execution – product positioning by segment
Table 8.5: Strategic execution – perceived customer value / quality
Table 8.6: Strategic execution – promotion / communications
Table 8.7: Strategic execution – product distribution by region
CHAPTER 9. Company Profile of Siemens
Table 9.1: Markets Served – Siemens
Table 9.2: Lucintel triad – Siemens
Table 9.3: Financial Benchmarking of Siemens against best and against Top three and top five industry players’ average
Table 9.4: Strategic execution – product positioning by segment
Table 9.5: Strategic execution – perceived customer value / quality
Table 9.6: Strategic execution – promotion / communications
Table 9.7: Strategic execution – product distribution by region
CHAPTER 3. Market Opportunity
Table 3.1: Industry parameters of global pulp and paper chemical industry
Table 3.2: Relative market attractiveness by region
Table 3.3: Regional revenue growth rate
Table 3.4: Segment revenue growth rate
CHAPTER 4. Competitive Benchmarking (Financial and Market)
Table 4.1: Financial benchmarking of top five global pulp and paper chemical companies
Table 4.2: Key financial parameters for top five pulp and paper chemical companies
Table 4.3: Regional revenue (US $B)
Table 4.4: Regional revenue (%)
Table 4.5: Competitors based on markets served
Table 4.6: Lucintel triad - Top five major players
CHAPTER 5. Company Profile of Abbott
Table 5.1: Market served: Abbott
Table 5.2: Lucintel triad – Abbott
Table 5.3: Financial Benchmarking of Abbott against best and against Top three and Top five industry players’ average
Table 5.4: Strategic execution – product positioning by segment
Table 5.5: Strategic execution – perceived customer value / quality
Table 5.6: Strategic execution – promotion / communications
Table 5.7: Strategic execution – product distribution by region
CHAPTER 6. Company Profile of General Electric
Table 6.1: Market served – General Electric
Table 6.2: Lucintel triad – General Electric
Table 6.3: Financial benchmarking of General Electric against best and against
Top three and Top five industry players’ average
Table 6.4: Strategic execution – product positioning by segment
Table 6.5: Strategic execution – perceived customer value / quality
Table 6.6: Strategic execution – promotion / communications
Table 6.7: Strategic execution – product distribution by region
CHAPTER 7. Company Profile of Philips
Table 7.1: Market served – Philips
Table 7.2: Lucintel triad – Philips
Table 7.3: Financial benchmarking of Philips against best and against Top three and Top five industry players’ average
Table 7.4: Strategic execution – product positioning by segment
Table 7.5: Strategic execution – perceived customer value / quality
Table 7.6: Strategic execution – promotion / communications
Table 7.7: Strategic execution – product distribution by region
CHAPTER 8. Company Profile of Roche
Table 8.1: Market served – Roche
Table 8.2: Lucintel triad – Roche
Table 8.3: Financial Benchmarking of Roche against best and against Top three and top five industry players’ average
Table 8.4: Strategic execution – product positioning by segment
Table 8.5: Strategic execution – perceived customer value / quality
Table 8.6: Strategic execution – promotion / communications
Table 8.7: Strategic execution – product distribution by region
CHAPTER 9. Company Profile of Siemens
Table 9.1: Markets Served – Siemens
Table 9.2: Lucintel triad – Siemens
Table 9.3: Financial Benchmarking of Siemens against best and against Top three and top five industry players’ average
Table 9.4: Strategic execution – product positioning by segment
Table 9.5: Strategic execution – perceived customer value / quality
Table 9.6: Strategic execution – promotion / communications
Table 9.7: Strategic execution – product distribution by region
